TessArae, GeneDx Develop Array-Based Tests for Noonan, Periodic Fever Syndromes
November 10, 2009
TessArae, GeneDx Develop Array-Based Tests for Noonan, Periodic Fever Syndromes
For TessArae, which specializes in developing pathogen-detection arrays, the deal with GeneDx is the first of its kind. The company said this week that it intends to pursue more opportunities in the genetic disease-testing arena.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- FDA Authorizes TessArae's RM-Flu Chip for Emergency H1N1 Testing
December 22, 2009 / BioArray News - Autism-Associated Variants Uncovered by Population Diagnostics, SickKids Team Could Yield Dx Tests
December 11, 2012 / BioArray News - Affymetrix's Shares Jump 30 Percent in June to Lead GWDN Index
July 1, 2011 / GenomeWeb Daily News - In 2010, Array Makers Saw CGH Become the Standard in Cytogenetics, Prepared for Next Wave of GWAS
January 4, 2011 / BioArray News - TessArae Partners with Israeli Testing Firm GGA to Design Cancer-Resequencing Chip
December 21, 2010 / BioArray News